3 Growth Shares For Your Nisa: AstraZeneca plc, Diageo plc And Unilever plc

AstraZeneca plc (LON:AZN), Diageo plc (LON:DGE) and Unilever plc (LON:ULVR) look to be three great growth picks for your new ISA.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

At the beginning of this month the much touted New ISA, or Nisa, came into existence.

The Nisa is a revolution for savers. The new product has a limit of £15,000, a substantial increase from the £11,880 allowed in the previous Stocks & Shares ISA. What’s more, you will be able to move freely between shares and cash at any time using the full £15,000 to invest in the stock market, cash or a mix of both.

For those investors who want to add some spice to their Nisa, here are three companies that are set to see their profits surge over the next few years.

Best of both worldsastrazeneca

Recent takeover candidate, AstraZeneca (LSE: AZN) (NYSE: AZN.US) is not only a company with great growth potential, the company’s shares also currently support a 4% dividend yield.

As part of its attempt to rebuff Pfizer, Astra made the claim that the company had the potential to nearly double its annual sales during the next 10 years — from $26 billion today to $45 billion by 2023.

If the company pulls it off, shareholders will be richly rewarded. There is no reason to suggest that the company cannot hit these lofty targets.

Indeed, it is believed that Astra’s current pipeline of oncology treatments is one of the best in the world. The company’s set of AZD9291 cancer treatments is expected to rack up sales of $3 billion, as its flexible nature means that the drug can be combined with other treatments to make several completely different products.

However, at present Astra’s sales are contracting, although current forecasts predict that they will start expanding again during 2016 and 2017. With a dividend yield of 4%, investors will be paid to wait.

Rapid expansion

DiageoDiageo’s (LSE: DGE) (NYSE: DEO.US) growth over the past decade has been nothing short of impressive. Nevertheless, it would appear that the company is just getting started.

Diageo has built itself into the largest alcoholic beverage brand in the world. The company’s drinks cabinet now contains some of the world’s best-known drinks brands including GuinnessSmirnoff vodka and Johnnie Walker whiskey.

Recently the company acquired around 50% of United Spirits, India’s largest spirit company. India’s whiskey consumption doubled during the period 2005 to 2010 and for Diageo, this market has remained largely out of reach.

Strict import laws and tariffs have prevent from Diego from entering the world’s largest whiskey market but control of United Spirits should change that.

Over the long term, Diageo is sure to profit from its Indian expansion.

Emerging marketsUnilever

My final Nisa growth pick is another play on India. Consumer goods giant, Unilever (LSE: ULVR) recently increased its stake in Hindustan Unilever Limited; Unilever’s Indian subsidiary. India is one of the world’s largest consumer markets, so Unilever’s presence within the region is exciting.

Further, Unilever is refocusing its global brand portfolio, selling off non-core, low-margin and low-growth food brands, diverting funds towards the company’s line of home care products. The home care side of the business is actually growing much faster than the food side.

Unilever is a solid pick for income seekers as well. The company currently supports a dividend yield of 3.4%.

Rupert does not own any share mentioned within this article. The Motley Fool owns shares in Unilever. 

More on Investing Articles

Investing Articles

These 3 things could make a Stocks and Shares ISA a no-brainer in 2026

The government and the FCA are doing their bit to try to steer investors towards a Stocks and Shares ISA…

Read more »

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

Revealed! The 10 best-performing FTSE 100 shares in 2025

It's been a year of golden gains for the FTSE 100 index, spearheaded by these 10 powerhouse stocks. But can…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Is it time to consider gobbling up these 3 FTSE 100 Christmas turkeys?

Our writer looks at the pros and cons of buying three of the FTSE 100’s (INDEXFTSE:UKX) worst performers over the…

Read more »

Investing Articles

Are Rolls-Royce shares a ticking time bomb after a 95% gain in 2025?

Rolls-Royce shares have been defying predictions of a fall for years now, while consistently smashing through analyst expectations.

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

I asked ChatGPT for a discounted cash flow analysis for Lloyds shares. This is what it said…

AI software can do complicated calculations in seconds. James Beard took advantage and asked ChatGPT for its opinion on the…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

Back to glory: is Aston Martin poised for growth stock stardom in 2026?

Growth stock hopes for Aston Martin quickly evaporated soon after flotation in 2018. But forecasts show losses narrowing sharply.

Read more »

British coins and bank notes scattered on a surface
Investing Articles

UK dividend stocks could look even more tempting if the Bank of England cuts rates this week!

Harvey Jones says returns on cash are likely to fall in the coming months, making the income paid by FTSE…

Read more »

Investing Articles

Up 115% with a 5.5% yield – are Aviva shares the ultimate FTSE 100 dividend growth machine?

Aviva shares have done brilliantly lately, and the dividend's been tip-top too. Harvey Jones asks if it's one of the…

Read more »